Accellix, Inc Expands Leadership Team and Announces Name Change
SAN JOSE, Calif. & JERUSALEM–(BUSINESS WIRE)–#Accellix–LeukoDx, Inc. (“the Company”), is pleased to announce the official name change to Accellix, Inc.…
Pharmaceuticals, Biotechnology and Life Sciences
SAN JOSE, Calif. & JERUSALEM–(BUSINESS WIRE)–#Accellix–LeukoDx, Inc. (“the Company”), is pleased to announce the official name change to Accellix, Inc.…
DUBLIN–(BUSINESS WIRE)–The “Global Knee Osteoarthritis Market [By Treatment – Non-Surgical Treatment (NSAIDS, Corticosteroids, Hyaluronic Acid Injections & Alternate Therapies) &…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
MGH will have guaranteed access to ElevateBio BaseCamp’s expert scientists, operators and facilities to accelerate the development of cell and…
Increases Second Quarter Revenues 10% to $6.3 Billion Posts Second Quarter GAAP EPS of $0.87 and Non-GAAP EPS of $1.18…
Company Aligns with FDA on Planned Confirmatory Study Design for Tazemetostat in Epithelioid Sarcoma Company to Host Conference Call Today,…
Quarterly net revenues of $86.7 million, representing 41 percent growth versus the second quarter 2018 The NovoTTF-100L™ System FDA approved…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global psoriatic arthritis therapeutics market is expected to post a CAGR of close to 9% during the period…
LONDON–(BUSINESS WIRE)–#Healthcare–The prevalence of vascular disease has increased at a significant rate over the years, which is fueling the demand…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced financial results for the first…